Advertisement

Topics

Catalyst Investors Company Profile

02:59 EDT 20th June 2019 | BioPortfolio

Catalyst Investors is a New York City-based growth equity firm focused on technology-enabled services including cloud computing, wireless infrastructure and digital media. Founded in 1999 and investing out of its $377 million fourth fund, Catalyst draws on deep sector expertise and an extensive network of industry leaders to work in true partnership with management to create long-term value. The firm makes both minority and majority investments of up to $60 million in rapidly growing companies. For more information, visit www.catalyst.com.


News Articles [617 Associated News Articles listed on BioPortfolio]

Catalyst Biosciences to provide results in one of its hematology trials in 3Q 2019

Catalyst Biosciences (NASDAQ:CBIO) Dr. Nassim Usman spoke with Proactive Investors at the BIO CEO & Investor Conference in New York. Catalyst is a clinical-stage biopharmaceutical company deve...

HC Wainright analyst reiterates $9 price target on Catalyst Pharmaceuticals

HC Wainright & Co senior analyst Andrew Fein explains to Proactive Investors why he's reiterating a Buy rating and $9 price target on biopharma company Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)...

Catalyst dives as FDA approves rival's rare disease drug

Jacobus Pharmaceutical's Ruzurgi is cleared for a different age range than Catalyst's Firdapse, yet investors appear concerned about off-label use eroding the latter's business. 

Heterogeneous catalyst goes enzymatic

Researchers demonstrated enzyme-like heterogeneous catalysis for the first time. They developed a highly active heterogeneous TiO2 photocatalyst incorporated with many single copper atoms. They used t...

STAT Plus: Did FDA unfairly treat Catalyst by approving a similar drug from another company?

Catalyst is exploring legal options after FDA's surprising approval of a similar treatment made by Jacobus. Does Catalyst have a case?

Catalyst OrthoScience gets FDA approval for Press Fit humeral implant

The new Press Fit humeral component is a continued evolution of the Catalyst CSR total shoulder system, which is a disruptive technology launched in 2016. Catalyst is planning The post Catalyst Ortho...

Idexx Introduces new canine progesterone test for Catalyst Dx & Catalyst One chemistry analyzers

Idexx Laboratories, Inc., a global leader in veterinary diagnostics and software, announced that it is introducing a new canine progesterone test for Catalyst Dx and Catalyst One chemistry analyzers. ...

Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drug

US Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Catalyst Pharma’s rare disease drug Firdapse, which is at the heart of a pricing s...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Firdapse [catalyst pharmaceuticals, inc.]

These highlights do not include all the information needed to use FIRDAPSE safely and effectively. See full prescribing information for FIRDAPSE. FIRDAPSE (amifampridine) tablets, for oral use Initial...

PubMed Articles [528 Associated PubMed Articles listed on BioPortfolio]

Magnetite/Iron Foil as an Effective and Nonfiltration Catalyst for Heterogeneous Fenton-like Reactions under Neutral Conditions.

A magnetite/iron foil (MIF) composite was synthesized as a heterogeneous Fenton-like catalyst. The MIF catalyst effectively degraded Rhodamine B under neutral conditions (degradation efficiency = 86%)...

Co-pyrolysis of biomass and soapstock in a downdraft reactor using a novel ZSM-5/SiC composite catalyst.

A ZSM-5/SiC composite catalyst was synthesized and characterized by Brunauer-Emmett-Teller analysis, X-ray diffraction, and scanning electron microscopy in this study. The composite catalyst had the c...

Heavy metal poisoned and regeneration of selective catalytic reduction catalysts.

Being poison to heterogeneous catalysts, Pb and As are important metals in the study of industrial NO emission reductions. A series of VO-WO/TiO-SiO catalysts poisoned by Pb and As were prepared throu...

A Hypercrosslinked Porous Porphyrin Aluminum(III) Tetracarbonylcobaltate as a Highly Active Heterogeneous Bimetallic Catalyst for the Ring-Expansion Carbonylation of Epoxides.

Development of an industrially viable catalyst for the ring expansion carbonylation of epoxides remains challenging in view of facile product separation and recyclability. Herein, we report a heteroge...

Magnetic hybrid of cyclodextrin nanosponge and polyhedral oligomeric silsesquioxane: Efficient catalytic support for immobilization of Pd nanoparticles.

For the first time a novel magnetic catalyst was prepared through hybridization of functionalized cyclodextrin nanosponges and octakis(3-chloropropyl)octasilsesquioxane followed by incorporation of Pd...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Newborn Heart Rate as a Catalyst for Improved Survival

Heart rate (HR) is not routinely assessed during newborn resuscitations in low- and lower-middle income countries (LMICs). Many non-breathing newborns classified as fresh stillbirths have ...

Basic Knowledge of CPR Among Close Relatives of Heart Patients-check Status Quo and Attemp to Establish a Potential Plan to Implement This Knowledge

Cardiac arrest is a public health problem and is the leading cause of death in many parts of the world. Cardiac arrest can occur inside the hospital and outside it. In the United States a...

Companies [800 Associated Companies listed on BioPortfolio]

Catalyst Investors

Catalyst Investors is a New York City-based growth equity firm focused on technology-enabled services including cloud computing, wireless infrastructure and digital media. Founded...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Pharmaceutical Partners

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is d...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

More Information about "Catalyst Investors" on BioPortfolio

We have published hundreds of Catalyst Investors news stories on BioPortfolio along with dozens of Catalyst Investors Clinical Trials and PubMed Articles about Catalyst Investors for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Investors Companies in our database. You can also find out about relevant Catalyst Investors Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record